Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gunjan Chandra has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Beyond Glycemic Control: Precision Medicine in Type 2 Diabetes Using Multi-Output Explainable Artificial Intelligence for Personalized SGLT2 and DPP-4 Therapy Selection

    by Anusha Ihalapathirana, Piia Lavikainen, Pekka Siirtola, Satu Tamminen, Gunjan Chandra, Tiina Laatikainen, Janne Martikainen, Juha Röning

    Traditional treatment strategies for Type 2 diabetes (T2D) adopt a “one-size-fits-all” approach, limiting individual effectiveness. This study presents an explainable, data-driven framework for multi-treatment and single-treatment selection of SGLT2 inhibitors (SGLT2-i) and DPP-4 inhibitors (DPP4-i) based on patient-specific health characteristics. Our approach evaluates treatment effectiveness across four outcomes—glycosylated hemoglobin (HbA1c), low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and body mass index (BMI)—to enable individualized treatment recommendations. The multi-treatment model, based on multi-output regression, achieved an R2 score of 0.44 and an RMSE of 5.58, identifying benefit subgroups for SGLT2-i and DPP4-i across all outcomes. Integrated with SHapley Additive exPlanations (SHAP) analysis, the model offers insights into the factors influencing treatment effects. The single-treatment selection algorithm achieved an accuracy of 0.47 and an F1 score of 0.46, showing a higher average treatment effect with SGLT2-i on all outcomes, notably in the reduction in HbA1c, LDL, and BMI and a modest increase in HDL. While DPP4-i demonstrated beneficial effects on HbA1c, LDL, and HDL, it was associated with an increase in BMI. These findings highlight the benefits of a multi-faceted, patient-centered precision medicine approach for T2D management, enabling treatment strategies that address individual health needs beyond HbA1c.

  • Open Access

    From registers to research: Data quality challenges in Finnish EHR – Enabling AI-driven research through data preparation and standardization

    by Anusha Ihalapathirana, Outi Laatikainen, Taneli Mattila, Gunjan Chandra, Jarmo Reponen, Satu Tamminen, Juha Röning, Pekka Siirtola

    Finland’s nationwide health registers and universal healthcare system provide comprehensive, longitudinal electronic health record data with strong potential for artificial intelligence-driven clinical research. Despite their coverage and richness, raw electronic health record datasets are not directly usable for advanced analytics due to fragmentation, heterogeneity, missingness, and inconsistencies in documentation and coding. This study describes data quality challenges encountered while preparing a breast cancer cohort (diagnosed 2012–2022) from the Wellbeing Services County of North Ostrobothnia as a preparatory step for artificial intelligence-based survival modelling. The initial dataset included 8074 patients across multiple domain-specific data files capturing diagnoses, laboratory results, pathology reports, medications, and procedural information. Following predefined cohort restrictions and preprocessing steps, 1967 patients remained for analysis. Identified challenges were grouped into four categories: 1. human-generated errors 2. decentralization-generated issues 3. time or system life-cycle–generated inconsistencies and 4. data governance/coding issues. The study adopts a qualitative research design aimed at systematically characterizing data quality challenges relevant to artificial intelligence application, and no predictive model was developed at this stage. The findings demonstrate that substantial preprocessing and data loss are often unavoidable in real-world electronic health record research and emphasize the need for standardized documentation, harmonized data structures, and closer collaboration between healthcare professionals, system developers, and data scientists to fully realize the potential of register-based electronic health record data in reliable artificial intelligence-driven research.

  • Open Access

    Explainable Prediction of Long-Term Glycated Hemoglobin Response Change in Finnish Patients with Type 2 Diabetes Following Drug Initiation Using Evidence-Based Machine Learning Approaches

    by Gunjan Chandra, Piia Lavikainen, Pekka Siirtola, Satu Tamminen, Anusha Ihalapathirana, Tiina Laatikainen, Janne Martikainen, Juha Röning

    Purpose: This study applied machine learning (ML) and explainable artificial intelligence (XAI) to predict changes in HbA1c levels, a critical biomarker for monitoring glycemic control, within 12 months of initiating a new antidiabetic drug in patients diagnosed with type 2 diabetes. It also aimed to identify the predictors associated with these changes. Patients and Methods: Electronic health records (EHR) from 10,139 type 2 diabetes patients in North Karelia, Finland, were used to train models integrating randomized controlled trial (RCT)-derived HbA1c change values as predictors, creating offset models that integrate RCT insights with real-world data. Various ML models—including linear regression (LR), multi-layer perceptron (MLP), ridge regression (RR), random forest (RF), and XGBoost (XGB)—were evaluated using R² and RMSE metrics. Baseline models used data at or before drug initiation, while follow-up models included the first post-drug HbA1c measurement, improving performance by incorporating dynamic patient data. Model performance was also compared to expected HbA1c changes from clinical trials. Results: Results showed that ML models outperform RCT model, while LR, MLP, and RR models had comparable performance, RF and XGB models exhibited overfitting. The follow-up MLP model outperformed the baseline MLP model, with higher R² scores (0.74, 0.65) and lower RMSE values (6.94, 7.62), compared to the baseline model (R²: 0.52, 0.54; RMSE: 9.27, 9.50). Key predictors of HbA1c change included baseline and post-drug initiation HbA1c values, fasting plasma glucose, and HDL cholesterol. Conclusion: Using EHR and ML models allows for the development of more realistic and individualized predictions of HbA1c changes, accounting for more diverse patient populations and their heterogeneous nature, offering more tailored and effective treatment strategies for managing T2D. The use of XAI provided insights into the influence of specific predictors, enhancing model interpretability and clinical relevance. Future research will explore treatment selection models.


  • Open Access

    Leveraging machine learning for predicting acute graft-versus-host disease grades in allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukaemia

    by Gunjan Chandra, Junfeng Wang, Pekka Siirtola, Juha Röning

    Orphan diseases, exemplified by T-cell prolymphocytic leukemia, present inherent challenges due to limited data availability and complexities in effective care. This study delves into harnessing the potential of machine learning to enhance care strategies for orphan diseases, specifically focusing on allogeneic hematopoietic cell transplantation (allo-HCT) in T-cell prolymphocytic leukemia. The investigation evaluates how varying numbers of variables impact model performance, considering the rarity of the disease. Utilizing data from the Center for International Blood and Marrow Transplant Research, the study scrutinizes outcomes following allo-HCT for T-cell prolymphocytic leukemia. Diverse machine learning models were developed to forecast acute graft-versus-host disease (aGvHD) occurrence and its distinct grades post-allo-HCT. Assessment of model performance relied on balanced accuracy, F1 score, and ROC AUC metrics. The findings highlight the Linear Discriminant Analysis (LDA) classifier achieving the highest testing balanced accuracy of 0.58 in predicting aGvHD. However, challenges arose in its performance during multi-class classification tasks. While affirming the potential of machine learning in enhancing care for orphan diseases, the study underscores the impact of limited data and disease rarity on model performance.


  • Open Access

    Leveraging Machine Learning for Predicting Acute Graft-versus-Host Disease Grades in Allogeneic Hematopoietic Cell Transplantation for T-cell Prolymphocytic Leukaemia

    by Gunjan Chandra, Junfeng Wang, Pekka Siirtola, Juha Röning

    Orphan diseases, exemplified by T-cell prolymphocytic leukemia, present inherent challenges due to limited data availability and complexities in effective care. This study delves into harnessing the potential of machine learning to enhance care strategies for orphan diseases, specifically focusing on allogeneic hematopoietic cell transplantation (allo-HCT) in T-cell prolymphocytic leukemia. The investigation evaluates how varying numbers of variables impact model performance, considering the rarity of the disease. Utilizing data from the Center for International Blood and Marrow Transplant Research, the study scrutinizes outcomes following allo-HCT for T-cell prolymphocytic leukemia. Diverse machine learning models were developed to forecast acute graft-versus-host disease (aGvHD) occurrence and its distinct grades post-allo-HCT. Assessment of model performance relied on balanced accuracy, F1 score, and ROC AUC metrics. The findings highlight the Linear Discriminant Analysis (LDA) classifier achieving the highest testing balanced accuracy of 0.58 in predicting aGvHD. However, challenges arose in its performance during multi-class classification tasks. While affirming the potential of machine learning in enhancing care for orphan diseases, the study underscores the impact of limited data and disease rarity on model performance.

  • Open Access

    Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients

    by Anusha Ihalapathirana, Konstantina Chalkou, Pekka Siirtola, Satu Tamminen, Gunjan Chandra, Pascal Benkert, Jens Kuhle, Georgia Salanti, Juha Röning


  • Open Access

    Predicting Emotion with Biosignals: A Comparison of Classification and Regression Models for Estimating Valence and Arousal Level Using Wearable Sensors

    by Pekka Siirtola, Satu Tamminen, Gunjan Chandra, Anusha Ihalapathirana, Juha Röning

    This study aims to predict emotions using biosignals collected via wrist-worn sensor and evaluate the performance of different prediction models. Two dimensions of emotions were considered: valence and arousal. The data collected by the sensor were used in conjunction with target values obtained from questionnaires. A variety of classification and regression models were compared, including Long Short-Term Memory (LSTM) models. Additionally, the effects of different normalization methods and the impact of using different sensors were studied, and the way in which the results differed between the study subjects was analyzed. The results revealed that regression models generally performed better than classification models, with LSTM regression models achieving the best results. The normalization method called baseline reduction was found to be the most effective, and when used with an LSTM-based regression model it achieved high accuracy in detecting valence (mean square error = 0.43 and R2-score = 0.71) and arousal (mean square error = 0.59 and R2-score = 0.81). Moreover, it was found that even if all biosignals were not used in the training phase, reliable models could be obtained; in fact, for certain study subjects the best results were obtained using only a few of the sensors.


  • Open Access

    Data-Driven Identification of Long-Term Glycemia Clusters and Their Individualized Predictors in Finnish Patients with Type 2 Diabetes

    by Piia Lavikainen, Gunjan Chandra, Pekka Siirtola, Satu Tamminen, Anusha T Ihalapathirana, Juha Röning, Tiina Laatikainen, Janne Martikainen

    Purpose: To gain an understanding of the heterogeneous group of type 2 diabetes (T2D) patients, we aimed to identify patients with the homogenous long-term HbA1c trajectories and to predict the trajectory membership for each patient using explainable machine learning methods and different clinical-, treatment-, and socio-economic-related predictors. Patients and Methods: Electronic health records data covering primary and specialized healthcare on 9631 patients having T2D diagnosis were extracted from the North Karelia region, Finland. Six-year HbA1c trajectories were examined with growth mixture models. Linear discriminant analysis and neural networks were applied to predict the trajectory membership individually. Results: Three HbA1c trajectories were distinguished over six years: “stable, adequate” (86.5%), “improving, but inadequate” (7.3%), and “fluctuating, inadequate” (6.2%) glycemic control. Prior glucose levels, duration of T2D, use of insulin only, use of insulin together with some oral antidiabetic medications, and use of only metformin were the most important predictors for the long-term treatment balance. The prediction model had a balanced accuracy of 85% and a receiving operating characteristic area under the curve of 91%, indicating high performance. Moreover, the results based on SHAP (Shapley additive explanations) values show that it is possible to explain the outcomes of machine learning methods at the population and individual levels. Conclusion: Heterogeneity in long-term glycemic control can be predicted with confidence by utilizing information from previous HbA1c levels, fasting plasma glucose, duration of T2D, and use of antidiabetic medications. In future, the expected development of HbA1c could be predicted based on the patient’s unique risk factors offering a practical tool for clinicians to support treatment planning.


  • Open Access

    Impacts of Data Synthesis: A Metric for Quantifiable Data Standards and Performances

    by Gunjan Chandra, Pekka Siirtola, Satu Tamminen, Mikael J. Knip, Riitta Veijola, Juha Röning

    Clinical data analysis could lead to breakthroughs. However, clinical data contain sensitive information about participants that could be utilized for unethical activities, such as blackmailing, identity theft, mass surveillance, or social engineering. Data anonymization is a standard step during data collection, before sharing, to overcome the risk of disclosure. However, conventional data anonymization techniques are not foolproof and also hinder the opportunity for personalized evaluations. Much research has been done for synthetic data generation using generative adversarial networks and many other machine learning methods; however, these methods are either not free to use or are limited in capacity. This study evaluates the performance of an emerging tool named synthpop, an R package producing synthetic data as an alternative approach for data anonymization. This paper establishes data standards derived from the original data set based on the utilities and quality of information and measures variations in the synthetic data set to evaluate the performance of the data synthesis process. The methods to assess the utility of the synthetic data set can be broadly divided into two approaches: general utility and specific utility. General utility assesses whether synthetic data have overall similarities in the statistical properties and multivariate relationships with the original data set. Simultaneously, the specific utility assesses the similarity of a fitted model’s performance on the synthetic data to its performance on the original data. The quality of information is assessed by comparing variations in entropy bits and mutual information to response variables within the original and synthetic data sets. The study reveals that synthetic data succeeded at all utility tests with a statistically non-significant difference and not only preserved the utilities but also preserved the complexity of the original data set according to the data standard established in this study. Therefore, synthpop fulfills all the necessities and unfolds a wide range of opportunities for the research community, including easy data sharing and information protection.